Related Experiment Videos

The endothelial cell cytoskeleton modulates extravascular polymorphonuclear leukocyte accumulations in vivo

I S Paterson1, J M Klausner, G Goldman

  • 1Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Insights

This study reveals that manipulating actin microfilaments in endothelial cells affects polymorphonuclear leukocyte diapedesis in vivo. Disrupting actin assembly with cytochalasin B enhances leukocyte migration, while promoting assembly with phalloidin reduces it.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Actin microfilaments are crucial for endothelial cell (EC) cytoskeleton structure and function.
  • In vitro studies suggest a role for actin microfilaments in polymorphonuclear leukocyte (PMN) diapedesis.
  • The in vivo role of the EC cytoskeleton in PMN diapedesis requires further investigation.

Purpose of the Study:

  • To investigate the in vivo role of the endothelial cell cytoskeleton in regulating PMN diapedesis.
  • To determine how manipulating actin microfilaments affects PMN accumulation at sites of inflammation.

Main Methods:

  • Small skin abrasions were created in rabbits to serve as experimental sites.
  • Local application of phalloidin (promotes microfilament assembly) or cytochalasin B (promotes microfilament disassembly) was used for cytoskeletal manipulation.
  • Chemotaxins, histamine, or saline were added secondarily to assess PMN accumulation.

Main Results:

  • Cytochalasin B treatment significantly increased PMN accumulation compared to saline control.
  • Phalloidin treatment significantly reduced PMN accumulation in response to various chemoattractants (LTB4, ZAP, histamine).
  • Initial cytochalasin B treatment of blisters enhanced PMN accumulation in response to LTB4 and histamine.

Conclusions:

  • Actin microfilament dynamics play a critical role in regulating PMN diapedesis in vivo.
  • Disassembly of actin filaments enhances PMN migration, while assembly inhibits it.
  • Targeting the EC cytoskeleton may offer therapeutic strategies for inflammatory conditions.

Related Concept Videos